Hsp therapy in conjunction with a low antigenicity diet

Details for Australian Patent Application No. 2005207891 (hide)

Owner Andromeda BioTech Ltd.

Inventors Rozing, Johannes; Elias, Dana

Agent Freehills

Pub. Number AU-B-2005207891

PCT Pub. Number WO2005/072056

Priority 60/539,330 28.01.04 US

Filing date 27 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 1 April 2010

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 September 2006 Amendment Made

  The nature of the amendment is: Delete co-inventor Brugman Sylvia

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/072056 Priority application(s): WO2005/072056

7 February 2008 Assignment before Grant

  DeveloGen Israel Ltd. The application has been assigned to Andromeda BioTech Ltd.

1 April 2010 Application Accepted

  Published as AU-B-2005207891

29 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005207895-Super-resolution image processing

2005207886-Novel brain natriuretic peptide variants and methods of use thereof